Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page
- Check5 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA sitewide NIH banner announcing website updates and a terminology transition was added, and the site revision advanced from v3.7.1 to v3.7.2. The page still displays a 403 error instead of the study record.SummaryDifference1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 error page; its footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study record content, blocking access to trial details and related information.SummaryDifference19%

- Check54 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, representing a new release of the page. This may include minor updates or fixes to the page structure or metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedA new revision stamp (Revision: v3.6.6) was added, replacing the previous v3.6.5. This indicates a small, internal update to the page's platform without altering study details.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.